Geode Capital Management, LLC Bio Affinity Technologies, Inc. Transaction History
Geode Capital Management, LLC
- $1.26 Trillion
- Q4 2024
A detailed history of Geode Capital Management, LLC transactions in Bio Affinity Technologies, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 99,551 shares of BIAF stock, worth $83,622. This represents 0.0% of its overall portfolio holdings.
Number of Shares
99,551
Previous 87,181
14.19%
Holding current value
$83,622
Previous $181,000
50.28%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding BIAF
# of Institutions
17Shares Held
536KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA261KShares$219,1290.0% of portfolio
-
Sheaff Brock Investment Advisors, LLC46.3KShares$38,8950.0% of portfolio
-
Captrust Financial Advisors Raleigh, NC27.9KShares$23,4230.0% of portfolio
-
State Street Corp Boston, MA17.6KShares$14,7840.0% of portfolio
-
Two Sigma Securities, LLC New York, NY14.4KShares$12,1120.0% of portfolio
About bioAffinity Technologies, Inc.
- Ticker BIAF
- Exchange
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 2,727,580
- Market Cap $2.29M
- Description
- bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is b...